Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Deciphering Mechanisms Underlying Cancer Immunogenicity — Stella

Home/Head and Neck Cancer/Deciphering Mechanisms Underlying Cancer Immunogenicity

View on ClinicalTrials.gov

Recruiting

Back to Head and Neck Cancer trials

Deciphering Mechanisms Underlying Cancer Immunogenicity

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

France

Hopital Larrey, Toulouse

Hopital Rangueil, Toulouse

Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse

Key details

Sponsor

Institut Claudius Regaud

Enrollment target

~1,100 participants

Started

January 2020

Primary completion

January 2033

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.